Fundz

Xilio Therapeutics, Inc. reported raising $50.2 Million in an initial SEC Form D filing, from an offering of $50.2 Million

PUBLIC · XLOJan 21, 2021

Amount Raised

$50.2 Million

$50.2 Million sold, per SEC Form D (first sale Jan 21, 2021)

Round Type

Venture

WalthamBiotechnologyHealth CareTherapeutics

Quick answer

Xilio Therapeutics raised $50.2 Million in a funding round, dated January 21, 2021. Xilio Therapeutics is based in Waltham, Massachusetts, United States.

How much did Xilio Therapeutics raise?
Xilio Therapeutics raised $50.2 Million in a funding round on January 21, 2021.
What does Xilio Therapeutics do?
Xilio is a Waltham, Massachusetts-based clinical-stage biopharmaceutical company focused on defeating cancer.
Where is Xilio Therapeutics based and how big is it?
Xilio Therapeutics is based in Waltham, Massachusetts, United States. Fundz records about 88 employees.
Who are the decision-makers at Xilio Therapeutics?
Fundz holds 1 contact at Xilio Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Xilio Therapeutics that raised within 45 days of this round, from Fundz verified event records.

Who to call at Xilio Therapeutics, and when

A new round usually means Xilio Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Xilio Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Xilio Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Xilio Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Xilio Therapeutics

Location

Waltham, Massachusetts, United States

About

Xilio is a Waltham, Massachusetts-based clinical-stage biopharmaceutical company focused on defeating cancer. The company’s proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. Xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Xilio Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts12 people are listed at Xilio Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Xilio Therapeutics's next move

See what Strategic adds

Xilio Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.